1 month Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Given Consensus Rating of “Moderate Buy” by BrokeragesMarketBeat
Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the fourteen research firms that are covering the firm, MarketBeat.com reports. Three research analysts have rated t…
Nasdaq 100 · Pharmaceuticals · Science
X